With the rise in demand of gene therapies as an alternative treatment to genetic and chronic diseases number of venture capital firms are coming forward to help biotech companies in raising funds for new gene therapies, says RNCOS.
Noida, UP -- (SBWIRE) -- 12/10/2014 -- According to a new research report by RNCOS entitled, "Global Gene Therapy Market Outlook 2018", with the rise in demand of gene therapies as an alternative treatment to genetic and chronic diseases number of venture capital firms are coming forward to help biotech companies in raising funds for new gene therapies. Venture Capital Firms have been progressively investing into gene therapy space by providing ample funding support to biotech Startups. For instance, Philadelphia based gene therapy company Spark Therapeutics raised US$ 72.8 Million from Sofinnova Ventures to launch a gene therapy for genetic form of blindness.
Similarly, Seattle-based Start up Juno Therapeutics had landed US$ 120 Million in a deal led by Arch Venture Partners and the Alaska Permanent Fund. The company is working on technologies to treat late-stage cancer patients for whom other treatments have been failed. Orbimed Advisors led a US$ 30 Million Series A round of funding for San Francisco-based biotech company Audentes Therapeutics. It is developing therapy for genetic form of muscular disorder. Venture capital firms 5AM Ventures and Versant Ventures also participated in the funding round. The company would be using the funds to advance its two lead programmes, AT001 for X-linked Myotubular Myopathy and AT002 for Pompe disease, as well as to evaluate additional candidate programmes.
The report is spread in over 120 pages and provides an in-depth research and rational analysis of the global gene therapy market. A brief overview of the key geographies in the gene therapy segment and the regulatory scenario governing the industry has also been included in the study to present a balanced outlook. The report covers how major trends and drivers, including nanotechnology, advanced therapies to treat chronic diseases etc will propel the industry's growth. With a view to understand the competitive landscape, the profiles of key market players are included in the report to present a complete picture of the global gene therapy market.
For FREE SAMPLE of this report visit:
Check Related REPORTS on:
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.